vs

Side-by-side financial comparison of La Rosa Holdings Corp. (LRHC) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

Organogenesis Holdings Inc. is the larger business by last-quarter revenue ($37.2M vs $20.2M, roughly 1.8× La Rosa Holdings Corp.). On growth, La Rosa Holdings Corp. posted the faster year-over-year revenue change (3.2% vs -57.1%). Over the past eight quarters, La Rosa Holdings Corp.'s revenue compounded faster (72.5% CAGR vs -46.5%).

V. La Rosa and Sons Macaroni Company was founded in 1914 by Vincenzo La Rosa, a Sicilian immigrant. The company eventually became one of the largest regional brands in the United States producing over 40 varieties of pasta.

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

LRHC vs ORGO — Head-to-Head

Bigger by revenue
ORGO
ORGO
1.8× larger
ORGO
$37.2M
$20.2M
LRHC
Growing faster (revenue YoY)
LRHC
LRHC
+60.2% gap
LRHC
3.2%
-57.1%
ORGO
Faster 2-yr revenue CAGR
LRHC
LRHC
Annualised
LRHC
72.5%
-46.5%
ORGO

Income Statement — Q3 FY2025 vs Q1 FY2026

Metric
LRHC
LRHC
ORGO
ORGO
Revenue
$20.2M
$37.2M
Net Profit
$-5.5M
Gross Margin
8.4%
30.8%
Operating Margin
-24.7%
-185.1%
Net Margin
-27.4%
Revenue YoY
3.2%
-57.1%
Net Profit YoY
-125.7%
EPS (diluted)
$-5.44

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LRHC
LRHC
ORGO
ORGO
Q1 26
$37.2M
Q4 25
$225.6M
Q3 25
$20.2M
$150.9M
Q2 25
$23.2M
$101.0M
Q1 25
$17.5M
$86.7M
Q4 24
$17.7M
$126.7M
Q3 24
$19.6M
$115.2M
Q2 24
$19.1M
$130.2M
Net Profit
LRHC
LRHC
ORGO
ORGO
Q1 26
Q4 25
$43.7M
Q3 25
$-5.5M
$21.6M
Q2 25
$78.4M
$-9.4M
Q1 25
$-95.7M
$-18.8M
Q4 24
$-5.1M
$7.7M
Q3 24
$-2.5M
$12.3M
Q2 24
$-2.3M
$-17.0M
Gross Margin
LRHC
LRHC
ORGO
ORGO
Q1 26
30.8%
Q4 25
Q3 25
8.4%
Q2 25
8.0%
Q1 25
8.8%
72.6%
Q4 24
8.9%
75.5%
Q3 24
8.3%
76.7%
Q2 24
8.3%
77.6%
Operating Margin
LRHC
LRHC
ORGO
ORGO
Q1 26
-185.1%
Q4 25
28.1%
Q3 25
-24.7%
13.7%
Q2 25
-10.6%
-12.5%
Q1 25
-26.7%
-30.9%
Q4 24
-17.1%
8.1%
Q3 24
-8.9%
5.4%
Q2 24
-9.7%
-10.7%
Net Margin
LRHC
LRHC
ORGO
ORGO
Q1 26
Q4 25
19.4%
Q3 25
-27.4%
14.3%
Q2 25
337.8%
-9.3%
Q1 25
-546.5%
-21.7%
Q4 24
-28.7%
6.1%
Q3 24
-12.5%
10.7%
Q2 24
-12.2%
-13.1%
EPS (diluted)
LRHC
LRHC
ORGO
ORGO
Q1 26
Q4 25
$0.31
Q3 25
$-5.44
$0.11
Q2 25
$15.25
$-0.10
Q1 25
$-5.86
$-0.17
Q4 24
$28.54
$0.05
Q3 24
$-16.49
$0.09
Q2 24
$-12.49
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LRHC
LRHC
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$4.0M
$91.4M
Total DebtLower is stronger
$642.8K
Stockholders' EquityBook value
$1.6M
Total Assets
$21.7M
$520.0M
Debt / EquityLower = less leverage
0.41×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LRHC
LRHC
ORGO
ORGO
Q1 26
$91.4M
Q4 25
$93.7M
Q3 25
$4.0M
$63.7M
Q2 25
$5.1M
$73.1M
Q1 25
$2.9M
$110.0M
Q4 24
$1.4M
$135.6M
Q3 24
$1.8M
$94.3M
Q2 24
$1.6M
$89.9M
Total Debt
LRHC
LRHC
ORGO
ORGO
Q1 26
Q4 25
Q3 25
$642.8K
Q2 25
$644.3K
Q1 25
$645.9K
Q4 24
$647.6K
Q3 24
$649.2K
$62.3M
Q2 24
$650.8K
$63.8M
Stockholders' Equity
LRHC
LRHC
ORGO
ORGO
Q1 26
Q4 25
$300.1M
Q3 25
$1.6M
$255.1M
Q2 25
$3.4M
$233.2M
Q1 25
$-87.5M
$242.9M
Q4 24
$2.6M
$262.9M
Q3 24
$5.0M
$278.5M
Q2 24
$4.7M
$263.5M
Total Assets
LRHC
LRHC
ORGO
ORGO
Q1 26
$520.0M
Q4 25
$598.7M
Q3 25
$21.7M
$509.8M
Q2 25
$22.9M
$461.1M
Q1 25
$21.0M
$467.4M
Q4 24
$19.4M
$497.9M
Q3 24
$19.7M
$446.3M
Q2 24
$18.7M
$443.2M
Debt / Equity
LRHC
LRHC
ORGO
ORGO
Q1 26
Q4 25
Q3 25
0.41×
Q2 25
0.19×
Q1 25
Q4 24
0.25×
Q3 24
0.13×
0.22×
Q2 24
0.14×
0.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LRHC
LRHC
ORGO
ORGO
Operating Cash FlowLast quarter
$-1.3M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LRHC
LRHC
ORGO
ORGO
Q1 26
Q4 25
$39.4M
Q3 25
$-1.3M
$3.1M
Q2 25
$-1.4M
$-32.9M
Q1 25
$-3.5M
$-19.9M
Q4 24
$-1.1M
$10.9M
Q3 24
$-591.6K
$8.7M
Q2 24
$-803.1K
$4.7M
Free Cash Flow
LRHC
LRHC
ORGO
ORGO
Q1 26
Q4 25
$34.8M
Q3 25
$844.0K
Q2 25
$-36.5M
Q1 25
$-23.6M
Q4 24
$7.6M
Q3 24
$6.1M
Q2 24
$2.9M
FCF Margin
LRHC
LRHC
ORGO
ORGO
Q1 26
Q4 25
15.4%
Q3 25
0.6%
Q2 25
-36.1%
Q1 25
-27.2%
Q4 24
6.0%
Q3 24
5.3%
Q2 24
2.2%
Capex Intensity
LRHC
LRHC
ORGO
ORGO
Q1 26
Q4 25
2.1%
Q3 25
1.5%
Q2 25
3.6%
Q1 25
4.2%
Q4 24
2.7%
Q3 24
2.2%
Q2 24
1.4%
Cash Conversion
LRHC
LRHC
ORGO
ORGO
Q1 26
Q4 25
0.90×
Q3 25
0.14×
Q2 25
-0.02×
Q1 25
Q4 24
1.43×
Q3 24
0.71×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LRHC
LRHC

Real Estate Residential Brokerage Services$16.8M83%
Transferred Over Time$3.5M17%

ORGO
ORGO

Segment breakdown not available.

Related Comparisons